Company profile
UK company 08146622, incorporated on 17 July 2012.
Gelmetix Transforming Individuals' Lives
Gelmetix Limited is a UK company with status Active founded in 2012 based in Yorkshire and the Humber.
Company number 08146622
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
The company aims to transfer microgel technology to the clinic in the context of intervertebral disc repair
Gelmetix has developed a non-surgical treatment for lower back pain that utilises injectable bio-materials that are specifically designed to replicate the bio-mechanical properties of a healthy inter-vertebral disc.
The company has attracted more than £1 M of inward investment.
1 Sep 2017 to 31 Mar 2018
Osteoarthritis [OA] is a significant global healthcare challenge. It is a long-term chronic disease, is characterized by the thinning of synovial fluid and subsequent deterioration of cartilage in joints which results in bones rubbing together and creating stiffness, immobilising pain, and impaired movement. OA most commonly affects seniors and is expecte...
1 Aug 2015 to 31 Mar 2018
Chronic lower back pain (CLBP) will affect half of the EU population at some time in their lives. CLBP affects 2.5m UK patients at any time; direct medical costs per patient are £1,074pa. Time off costs £2,276 p/p pa. Total impact including benefit/insurance is £12bn+. CLBP's most common cause is degeneration in the patient’s intervertebral disc (IVD). A ...
1 Jun 2013 to 28 Feb 2014
The purpose of the project is to validate an injectable hydrogel material and the application of the material in treating chronic lower back pain (CLBP). CLBP affects 55m people in the western world and costs society billions of pounds a year. It is difficult to clinically manage and most treatment regimes are either ineffective or require invasive surgic...
1 Oct 2012 to 28 Feb 2013
The purpose of the project is for the development of a Business Plan and Investment memorandum for Gelexir Ltd. This will include market assessment and competitive analysis, business strategy, regulatory approval plan, IP review as well as product development and testing plan. The Plan will be used for raising sufficient funds from institutional and priva...
